» Articles » PMID: 20643931

RNAi Screen for Telomerase Reverse Transcriptase Transcriptional Regulators Identifies HIF1alpha As Critical for Telomerase Function in Murine Embryonic Stem Cells

Overview
Specialty Science
Date 2010 Jul 21
PMID 20643931
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

In various types of stem cells, including embryonic stem (ES) cells and hematopoietic stem cells, telomerase functions to ensure long-term self-renewal capacity via maintenance of telomere reserve. Expression of the catalytic component of telomerase, telomerase reverse transcriptase (Tert), which is essential for telomerase activity, is limiting in many types of cells and therefore plays an important role in establishing telomerase activity levels. However, the mechanisms regulating expression of Tert in cells, including stem cells, are presently poorly understood. In the present study, we sought to identify genes involved in the regulation of Tert expression in stem cells by performing a screen in murine ES (mES) cells using a shRNA expression library targeting murine transcriptional regulators. Of 18 candidate transcriptional regulators of Tert expression identified in this screen, only one candidate, hypoxia inducible factor 1 alpha (Hif1alpha), did not have a significant effect on mES cell morphology, survival, or growth rate. Direct shRNA-mediated knockdown of Hif1alpha expression confirmed that suppression of Hif1alpha levels was accompanied by a reduction in both Tert mRNA and telomerase activity levels. Furthermore, gradual telomere attrition was observed during extensive proliferation of Hif1alpha-targeted mES cells. Switching Hif1alpha-targeted mES cells to a hypoxic environment largely restored Hif1alpha levels, as well as Tert expression, telomerase activity levels, and telomere length. Together, these findings suggest a direct effect of Hif1alpha on telomerase regulation in mES cells, and imply that Hif1alpha may have a physiologically relevant role in maintenance of functional levels of telomerase in stem cells.

Citing Articles

Mechanisms of Breast Cancer Stem Cell Specification and Self-Renewal Mediated by Hypoxia-Inducible Factor 1.

Semenza G Stem Cells Transl Med. 2023; 12(12):783-790.

PMID: 37768037 PMC: 10726407. DOI: 10.1093/stcltm/szad061.


Pathomechanisms of Prenatally Programmed Adult Diseases.

Sulyok E, Farkas B, Bodis J Antioxidants (Basel). 2023; 12(7).

PMID: 37507894 PMC: 10376205. DOI: 10.3390/antiox12071354.


Genome-wide screens identify specific drivers of mutant promoters.

Shanmugam R, Ozturk M, Low J, Akincilar S, Chua J, Thangavelu M Proc Natl Acad Sci U S A. 2022; 119(3).

PMID: 35027447 PMC: 8784157. DOI: 10.1073/pnas.2105171119.


Hypoxia Predicts Poor Prognosis in Neuroblastoma Patients and Associates with Biological Mechanisms Involved in Telomerase Activation and Tumor Microenvironment Reprogramming.

Cangelosi D, Morini M, Zanardi N, Sementa A, Muselli M, Conte M Cancers (Basel). 2020; 12(9).

PMID: 32825087 PMC: 7563184. DOI: 10.3390/cancers12092343.


Identification of genes involved in the regulation of TERT in hepatocellular carcinoma.

Amisaki M, Tsuchiya H, Sakabe T, Fujiwara Y, Shiota G Cancer Sci. 2018; 110(2):550-560.

PMID: 30447097 PMC: 6361581. DOI: 10.1111/cas.13884.


References
1.
Forsythe J, Jiang B, Iyer N, Agani F, Leung S, Koos R . Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol. 1996; 16(9):4604-13. PMC: 231459. DOI: 10.1128/MCB.16.9.4604. View

2.
Harrison D, Astle C . Loss of stem cell repopulating ability upon transplantation. Effects of donor age, cell number, and transplantation procedure. J Exp Med. 1982; 156(6):1767-79. PMC: 2186863. DOI: 10.1084/jem.156.6.1767. View

3.
Greenwood M, Lansdorp P . Telomeres, telomerase, and hematopoietic stem cell biology. Arch Med Res. 2004; 34(6):489-95. DOI: 10.1016/j.arcmed.2003.07.003. View

4.
Vaziri H, Dragowska W, Allsopp R, Thomas T, Harley C, Lansdorp P . Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci U S A. 1994; 91(21):9857-60. PMC: 44916. DOI: 10.1073/pnas.91.21.9857. View

5.
Vaziri H, Schachter F, Uchida I, Wei L, Zhu X, Effros R . Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet. 1993; 52(4):661-7. PMC: 1682068. View